USP10 Inhibitors

USP10 inhibitors comprise a diverse array of chemicals that indirectly modulate the function and activity of USP10, a ubiquitin-specific protease involved in various cellular processes, including DNA damage response and autophagy. These inhibitors primarily function by targeting pathways and processes related to the ubiquitin-proteasome system, cellular stress responses, and signaling pathways where USP10 plays a role. Compounds such as MG132, Bortezomib, and Lactacystin, all proteasome inhibitors, can influence the ubiquitin-proteasome system, thereby potentially impacting USP10's role in protein degradation and turnover. N-Ethylmaleimide, which alkylates free sulfhydryl groups, can modify protein interactions and potentially affect USP10 activity by altering its substrate specificity or interaction with regulatory proteins.

Other inhibitors, such as PIK-75 and LY294002, which inhibit PI3K, and Rapamycin, an mTOR inhibitor, can affect signaling pathways related to USP10's function in stress response and autophagy. Natural compounds like Curcumin and Resveratrol modulate various cellular pathways, potentially impacting USP10 activity through their effects on protein degradation and cell survival. Vorinostat, an HDAC inhibitor, and Sulfasalazine, which inhibits the NF-κB pathway, represent another approach to modulating USP10 activity by influencing gene expression and inflammatory pathways. Additionally, Geldanamycin, an Hsp90 inhibitor, can disrupt protein folding and signaling pathways, indirectly affecting USP10 activity.